Lavipharm S.A. (ATH:LAVI)
1.578
+0.014 (0.90%)
Sep 23, 2026, 5:09 PM EET
Lavipharm Market Cap
Lavipharm has a market cap or net worth of €267.1 million as of September 23, 2026. Its market cap has increased by 93.09% in one year.
Market Cap
267.10M
Enterprise Value
304.75M
Revenue
70.32M
Ranking
n/a
PE Ratio
47.66
Stock Price
€1.58
ChartMarket Cap Chart
Since October 21, 1996, Lavipharm's market cap has increased from 43.03M to 267.10M, an increase of 520.79%. That is a compound annual growth rate of 6.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 267.10M | 63.23% |
| Dec 31, 2025 | 163.63M | 22.01% |
| Dec 31, 2024 | 134.11M | 0.36% |
| Dec 29, 2023 | 133.62M | 107.29% |
| Dec 30, 2022 | 64.46M | 117.58% |
| Dec 31, 2021 | 29.63M | 23.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Noval Property Real Estate Investment Company | 317.60M |
| Bank of Greece | 296.98M |
| Ideal Holdings | 284.07M |
| Real Consulting | 260.10M |
| Profile Systems & Software | 247.74M |
| Dimand | 247.40M |
| Intracom Holdings | 245.63M |
| Evropi Holdings Societe Anonyme | 244.85M |